PORTOLA PHARMACEUTICALS INC | Business Contracts

Amended and Restated Portola Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on May 11, 2020)

Offer Letter by and between Portola Pharmaceuticals, Inc. and Rajiv Patni dated December 19, 2019 (Filed With SEC on May 11, 2020)

Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and Odyssey Merger Sub Inc (Filed With SEC on May 7, 2020)

Amendment No. 1 to Credit Agreement, dated August 15, 2019, to the Credit Agreement, dated February 28, 2019 (Filed With SEC on November 5, 2019)

Sixth Amendment To Lease dated June 28, 2019 (Filed With SEC on August 7, 2019)

Manufacturing Services Agreement by and between Lonza AG and Portola Pharmaceuticals, Inc., effective as of August 15, 2017 (Filed With SEC on May 8, 2019)

Description of securities of Portola Pharmaceuticals, Inc. registered under Section 12 of the Exchange Act (Filed With SEC on February 28, 2020)

Underwriting Agreement, dated August 13, 2019 (Filed With SEC on August 14, 2019)

Amended and Restated Portola Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on August 7, 2019)

Portola Pharmaceuticals, Inc. 2013 Equity Incentive Plan and Amendment dated February 27, 2019 (Filed With SEC on May 8, 2019)

Portola Pharmaceuticals, Inc. Amended and Restated Inducement Plan and Amendment dated February 27, 2019 (Filed With SEC on May 8, 2019)

Offer Letter by and between Portola Pharmaceuticals, Inc. and Ernie Meyer dated June 26, 2018 (Filed With SEC on May 8, 2019)

Offer Letter by and between Portola Pharmaceuticals, Inc. and Sheldon Koenig dated January 17, 2019 (Filed With SEC on May 8, 2019)

Consulting Agreement between Portola Pharmaceuticals, Inc. and Charles Homcy, M.D. dated as of March 28, 2019 (Filed With SEC on May 8, 2019)

Amended and Restated Pharmaceuticals, Inc. Inducement Plan (Filed With SEC on March 1, 2019)

Credit Agreement by and between Portola Pharmaceuticals, Inc. (the Borrower), certain domestic subsidiaries of the Borrower (the Guarantors), HCR Collateral Management, LLC (the... (Filed With SEC on March 1, 2019)

PORTOLA PHARMACEUTICALS INC (16)